Maryland Warrant Agreement of Immunomedics, Inc. is a legally binding contract between Immunomedics, Inc. and the warrant holder, granting the holder the right to purchase a specific number of shares of common stock at a predetermined price within a specified period. This agreement plays a crucial role in raising capital for Immunomedics, Inc. by allowing investors or warrant holders to exercise their right to buy shares at a fixed price. The Maryland Warrant Agreement provides clear terms and conditions regarding the issuance and exercise of warrants. It outlines the number of shares authorized, the exercise price per share, the expiration date, and any other relevant provisions. This agreement ensures transparency and fairness in the warrant issuance process, safeguarding the interests of both Immunomedics, Inc. and the warrant holders. Immunomedics, Inc. might have different types of Maryland Warrant Agreements, depending on various factors, such as the purpose of the warrant issuance, the target investor audience, or the specific terms agreed upon. Some common types of Maryland Warrant Agreements in the context of share purchase include: 1. Traditional Warrants: These are standard warrants that grant the holder the right, but not the obligation, to purchase a certain number of shares at a predetermined price within a specified timeframe. 2. Cashless Exercise Warrants: These warrants allow warrant holders to exercise their right to purchase shares without the need for upfront cash payment. The exercise price is often adjusted by deducting the market value of the shares at the time of exercising. 3. Equity Kickers: Equity kickers are warrants with additional features that provide an added incentive for investors. For example, these warrants may include rights to additional shares or options to convert the warrants into other securities. 4. Detachable Warrants: Detachable warrants are separate securities that can be detached or separated from the underlying bonds or preferred stock, allowing the warrant to be traded independently. 5. Registered Direct Offering Warrants: In some cases, Immunomedics, Inc. may offer warrants directly to accredited investors through a registered direct offering. These warrants allow qualified investors to purchase shares directly from the company at a negotiated price. It is essential for potential investors or warrant holders to thoroughly review the specific terms and conditions outlined in the Maryland Warrant Agreement before deciding to exercise their rights. This agreement provides a legal framework to protect the rights and promote a fair transaction process between Immunomedics, Inc. and the investors.